Joseph Horrigan
Direttore Tecnico/Scientifico/R&S presso AMO Pharma Ltd.
Profilo
Joseph Horrigan is currently an Associate Professor at The University of North Carolina at Charlotte and the Chief Medical Officer at AMO Pharma Ltd.
He previously worked as the VP-Clinical Development & Medical Affairs at Neuren Pharmaceuticals Ltd.
He earned a doctorate degree from the University of Rochester.
Posizioni attive di Joseph Horrigan
| Società | Posizione | Inizio |
|---|---|---|
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - |
AMO Pharma Ltd.
 AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Joseph Horrigan
| Società | Posizione | Fine |
|---|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Joseph Horrigan
| Rochester Christian University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Joseph Horrigan
